The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients

被引：13

作者：

DeVries, J. Hans ^{[1
,2
]}

Irs, Alar ^{[3
]}

Hillege, Hans L. ^{[4
]}

机构：

[1] European Med Agcy, Seconded Natl Expert, Domen Scarlattilaan 6, NL-1083 HS Amsterdam, Netherlands

[2] Locatie AMC, Dept Internal Med, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

[3] State Agcy Med, Tartu, Estonia

[4] Med Evaluat Board, Utrecht, Netherlands

来源：

EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 37期

关键词：

D O I：

10.1093/eurheartj/ehad429

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3492 / 3494

页数：3

共 7 条

[1]

[Anonymous], 2017, GUIDELINE CLIN INVES

[2]

[Anonymous], 2001, POINTS CONS APPL 1 M

[3] Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy [J].

Desai, Milind Y. ;

Owens, Anjali ;

Geske, Jeffrey B. ;

Wolski, Kathy ;

Naidu, Srihari S. ;

Smedira, Nicholas G. ;

Cremer, Paul C. ;

Schaff, Hartzell ;

McErlean, Ellen ;

Sewell, Christina ;

Li, Wanying ;

Sterling, Lulu ;

Lampl, Kathy ;

Edelberg, Jay M. ;

Sehnert, Amy J. ;

Nissen, Steven E. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (02) :95-108

[4] 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].

Gersh, Bernard J. ;

Maron, Barry J. ;

Bonow, Robert O. ;

Dearani, Joseph A. ;

Fifer, Michael A. ;

Link, Mark S. ;

Naidu, Srihari S. ;

Nishimura, Rick A. ;

Ommen, Steve R. ;

Rakowski, Harry ;

Seidman, Christine E. ;

Towbin, Jeffrey A. ;

Udelson, James E. ;

Yancy, Clyde W. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (25) :2703-2738

[5] CYP2C19 Allele Frequencies in Over 2.2 Million Direct-to-Consumer Genetics Research Participants and the Potential Implication for Prescriptions in a Large Health System [J].

Ionova, Yelena ;

Ashenhurst, James ;

Zhan, Jianan ;

Nhan, Hoang ;

Kosinski, Cindy ;

Tamraz, Bani ;

Chubb, Alison .

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (06) :1298-1306

[6] Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy [J].

Javidgonbadi, Davood ;

Andersson, Bert ;

Abdon, Nils-Johan ;

Schaufelberger, Maria ;

Ostman-Smith, Ingegerd .

OPEN HEART, 2019, 6 (01)

[7] Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Olivotto, Iacopo ;

Oreziak, Artur ;

Barriales-Villa, Roberto ;

Abraham, Theodore P. ;

Masri, Ahmad ;

Garcia-Pavia, Pablo ;

Saberi, Sara ;

Lakdawala, Neal K. ;

Wheeler, Matthew T. ;

Owens, Anjali ;

Kubanek, Milos ;

Wojakowski, Wojciech ;

Jensen, Morten K. ;

Gimeno-Blanes, Juan ;

Afshar, Kia ;

Myers, Jonathan ;

Hegde, Sheila M. ;

Solomon, Scott D. ;

Sehnert, Amy J. ;

Zhang, David ;

Li, Wanying ;

Bhattacharya, Mondira ;

Edelberg, Jay M. ;

Waldman, Cynthia Burstein ;

Lester, Steven J. ;

Wang, Andrew ;

Ho, Carolyn Y. ;

Jacoby, Daniel .

LANCET, 2020, 396 (10253) :759-769

← 1 →